TTK Healthcare Limited AI Stock Analysis
Want to see IN:TTKHLTCARE full AI Analyst Report?
TTK Healthcare Limited (TTKHLTCARE) AI Stock Analysis
TTK Healthcare Limited
(NSE:TTKHLTCARE)
The strong, low-leverage balance sheet is outweighed by deteriorating cash generation and weaker recent profitability. Negative technical momentum further pressures the score, while valuation remains only moderately supportive.
TTK Healthcare Limited (TTKHLTCARE) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 15.00B
- Dividend Yield
- 0.91%
- Average Volume (3M)
- 2,525
- Price to Earnings (P/E)
- 5.6
- Beta (1Y)
- 0.72
- Revenue Growth
- 11.29%
- EPS Growth
- 317.32%
- Country
- India
- Employees
- 1,478
- Sector
- General
- Sector Strength
- 55
- Industry
- Drug Manufacturers - General
TTK Healthcare Limited Business Overview & Revenue Model
Company Description
TTK Healthcare Limited is a diversified enterprise operating across multiple sectors in India and globally. Its extensive activities encompass animal welfare, offering veterinary therapeutic solutions and feed supplements. The human pharmaceuticals d...
TTK Healthcare Limited Financial Statement Overview
Summary
The balance sheet is strong with low leverage and an expanded equity base, but weaker recent profitability and sustained negative operating and free cash flow materially reduce the financial score.
Income Statement
62PositiveBalance Sheet
82Very PositiveCash Flow
33Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.37B | 8.57B | 8.73B | 7.48B | 7.25B | 5.99B |
| Gross Profit | 4.13B | 2.80B | 5.04B | 4.07B | 3.77B | 3.09B |
| EBITDA | 865.03M | 261.76M | 1.06B | 999.35M | 797.92M | 412.65M |
| Net Income | 2.77B | 656.80M | 816.57M | 628.42M | 6.40B | 415.88M |
Balance Sheet | ||||||
| Total Assets | 16.51B | 13.29B | 12.81B | 12.01B | 11.70B | 5.59B |
| Cash, Cash Equivalents and Short-Term Investments | 10.52B | 9.75B | 8.55B | 8.45B | 8.47B | 2.73B |
| Total Debt | 283.05M | 243.78M | 242.19M | 228.11M | 273.29M | 222.13M |
| Total Liabilities | 3.05B | 2.14B | 2.16B | 2.00B | 2.17B | 2.29B |
| Stockholders Equity | 13.47B | 11.15B | 10.65B | 10.01B | 9.53B | 3.30B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -269.50M | -168.16M | -153.27M | -377.75M | 385.02M |
| Operating Cash Flow | 0 | -211.48M | -39.76M | -49.43M | -260.76M | 449.96M |
| Investing Cash Flow | 0 | 515.79M | 201.03M | 284.94M | 329.59M | -305.47M |
| Financing Cash Flow | 0 | -175.56M | -180.81M | -219.11M | -124.26M | -51.77M |
TTK Healthcare Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:TTKHLTCARE, the sentiment is Positive. The current price of 1093.00 is above the 20-day moving average (MA) of 961.46, above the 50-day MA of 1019.53, and above the 200-day MA of 955.07, indicating a bullish trend. The MACD of -11.42 indicates Negative momentum. The RSI at 64.37 is Neutral, neither overbought nor oversold. The STOCH value of 70.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:TTKHLTCARE.
TTK Healthcare Limited Peers Comparison
Overall Rating
IN:CIPLA73Outperform
IN:GLAXO73Outperform
IN:ABBOTINDIA69Neutral
IN:SANOFI65Neutral
IN:TTKHLTCARE55Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | INR 1.12T | 38.70 | ― | 2.10% | -0.74% | -46.77% | |
| 73Outperform | INR 456.30B | 39.71 | ― | 2.11% | 12.12% | 20.03% | |
| 69Neutral | INR 549.48B | 33.19 | ― | 2.03% | 7.21% | 9.54% | |
| 65Neutral | INR 74.32B | 20.37 | ― | 3.82% | -5.74% | 2.30% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | INR 15.44B | 5.60 | ― | 0.91% | 11.29% | 317.32% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:TTKHLTCARE | TTK Healthcare Limited | 1093.00 | -27.83 | -2.48% | |
| IN:ABBOTINDIA | Abbott India Limited | 25858.75 | -3045.87 | -10.54% | |
| IN:CIPLA | Cipla Ltd | 1383.00 | -129.15 | -8.54% | |
| IN:GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 2693.55 | 237.49 | 9.67% | |
| IN:SANOFI | Sanofi India Limited | 3227.30 | -1184.95 | -26.86% | |
| IN:SANOFICONR | Sanofi Consumer Healthcare India Limited | 3525.95 | -1095.86 | -23.71% |
TTK Healthcare Limited Corporate Events
TTK Healthcare Publishes Notice on SEBI Securities Window
TTK Healthcare Limited is a healthcare-sector company, although the release does not provide details about its primary products, services, or market focus. The company announced that it published a newspaper notice and shared it on LinkedIn regarding...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 31, 2026
